Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Transthyretin Cardiac Amyloidosis in Heart Failure With Preserved Ejection Fraction: A Community Study

NCT03414632 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03414632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03414632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Transthyretin Cardiac Amyloidosis in Heart Failure With Preserved Ejection Fraction: A Community Study
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
December 1, 2017
Completion date
March 31, 2020
Enrollment
287 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with preserved ejection fraction